Filana Therapeutics, Inc. Accrued Liabilities, Current
Filana Therapeutics, Inc. (FLNA) had Accrued Liabilities, Current of $7.04 million as of 2023-06-30, per its 10-Q filed 2023-08-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-08-03
- 2023-06-30: Accrued Liabilities, Current $7.04M.
- 2023-03-31: Accrued Liabilities, Current $5.28M.
- 2022-12-31: Accrued Liabilities, Current $2.28M.
- 2022-09-30: Accrued Liabilities, Current $4.10M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2023-06-30 | $7.04M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $5.28M 10-Q · filed 2023-05-01 |
| 2022-12-31 | $2.28M 10-Q · filed 2023-08-03 |
| 2022-09-30 | $4.10M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $3.32M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $2.92M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.80M 10-K · filed 2023-02-28 |
| 2021-09-30 | $3.25M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.46M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $1.55M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $719.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $558.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $755.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $387.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $777.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $415.00K 10-Q · filed 2019-10-29 |
| 2019-06-30 | $179.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $243.00K 10-Q · filed 2019-05-02 |
| 2018-12-31 | $156.00K 10-K · filed 2020-03-26 |
| 2018-03-31 | $18.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $399.00K 10-K · filed 2019-03-29 |
| 2017-06-30 | $32.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $8.00K 10-Q · filed 2017-04-26 |
| 2016-12-31 | $27.00K 10-K · filed 2018-02-06 |
| 2016-09-30 | $744.00K 10-Q · filed 2016-10-26 |
| 2016-06-30 | $641.00K 10-Q · filed 2016-07-19 |
| 2016-03-31 | $818.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $894.00K 10-K · filed 2017-03-07 |
| 2015-09-30 | $642.00K 10-Q · filed 2015-11-09 |
| 2014-12-31 | $25.00K 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |